Gene therapy for lysosomal storage disorders: a good start

Area of Science:

• Biochemistry
• Genetics
• Cell Biology

Background:

• Lysosomal storage disorders (LSDs) are inherited diseases caused by enzyme deficiencies, leading to cellular damage from accumulated substances.
• The lysosome-specific cross-correction mechanism, where normal cells correct deficient neighbors, is a key therapeutic target.

Purpose of the Study:

• To review current gene therapy (GT) strategies for lysosomal storage disorders (LSDs).
• To discuss the impact of GT on LSD phenotypes in preclinical models and human patients.

Main Methods:

• Review of existing literature on gene therapy approaches for lysosomal storage disorders.
• Analysis of studies demonstrating the efficacy of gene therapy in animal models and clinical trials.

Main Results:

• Gene therapy shows potential for correcting the biochemical and pathological consequences of LSDs.
• Studies in animal models and patients indicate positive impacts of GT on disease phenotypes.

Conclusions:

• Gene therapy is a viable and evolving treatment strategy for various lysosomal storage disorders.
• Further research and clinical application of GT are crucial for managing LSDs effectively.